Medtronic plc Stock News

Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.

Semiconductor stocks are surging thanks to the artificial intelligence (AI) boom driven by Nvidia Co. NASDAQ: NVDA and Advanced Micro Devices Inc. NASDAQ: AMD. The VanEck Semiconductor ETF is up 28.66

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its d

Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.

Medical device maker Medtronic PLC NYSE: MDT is a Dividend Aristocrat in the medical and healthcare sectors. The medical device maker has raised its dividend payout for 46 consecutive years through bu

Medtronic is a leading medical device maker that continues to get bigger and more diversified. DexCom's continuous glucose monitoring devices are crucial for diabetics, enabling strong growth.

Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.

Medtronic is the world's largest medical device company, and it has a 46-year streak of consecutive annual dividend raises. Cigarette sales are steadily declining, but Altria Group's bottom line keeps

Medtronic MDT (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and

Thesis & Performance: Previous analysis suggested a fair price of $137.6; Q3 2024 earnings beat estimates, affirming my "strong buy" recommendation. Financial Overview: Q3 2024 earnings reported reven

Medtronic's choice to retain its PMRI Business is mainly driven by the improved performance of its Patient Monitoring segment in recent times, is a result of a comprehensive evaluation of its portfoli

Medtronic's business showed signs of promise in Q3, with revenue growth of around 5%. The company is exiting its ventilator product line, which should improve profitability.

Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang fo

Medtronic boasts nearly five decades of dividend growth. Currency exchange rates and inflation have been hurting its profits.

Medtronic beat revenue and earnings estimates for its fiscal third quarter. Growth was broad-based across product portfolios.